Showing results (1361-1370 of 2,361) with videos related to
Sort By:
Pageof 237
Clinical Neuropharmacology|December 1, 1992
The clinical efficacy of single morning doses of levodopa methyl ester: dispersible Madopar and Sinemet plus in Parkinson diseaseM J Steiger, F Stocchi, L Bramante, et al.Clinical Neuropharmacology|February 1, 1992
Motor response to repeated dopaminergic stimulation in Parkinson's diseaseJ A Obeso, M R Luquin, F Grandas, et al.Clinical Neuropharmacology|January 1, 1992
Interaction between aminergic systems in mesolimbic structures: the importance of 5-HT2, D2 and D1 receptors in the olfactory tubercle for the atypical profile of neurolepticsA R Cools, E Prinssen, B A EllenbroekClinical Neuropharmacology|April 3, 2003
Methyllycaconitine fails to inhibit electrically precipitated tonic hindlimb extension in miceStephen I Deutsch, Richard B Rosse, Alan S Bellack, et al.Clinical Neuropharmacology|April 3, 2003
Study of circadian melatonin secretion pattern at different stages of Parkinson's diseaseR Bordet, D Devos, S Brique, et al.Clinical Neuropharmacology|August 5, 2003
Waiting for ON: a major problem in patients with Parkinson disease and ON/OFF motor fluctuationsDoron Merims, Ruth Djaldetti, Eldad MelamedClinical Neuropharmacology|August 5, 2003
Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibitionCarlo Cattaneo, Carla Caccia, Antonio Marzo, et al.Clinical Neuropharmacology|April 1, 1992
Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophreniaR B Rosse, B L Schwartz, S Zlotolow, et al.Clinical Neuropharmacology|December 1, 1992
Synaptic plasticity in the rat striatum following chronic haloperidol treatmentJ M Kerns, D K Sierens, L C Kao, et al.Clinical Neuropharmacology|December 4, 2003
Noradrenergic drugs for levodopa-induced dyskinesiaCarlo Colosimo, Alessandra CrausPageof 237